US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 2.6350
- +0.1250+4.98%
Close Nov 27 16:00 ET
- 2.6300
- -0.0050-0.19%
Post 20:01 ET
2.78MMarket Cap-270P/E (TTM)
2.6725High2.4500Low42.70KVolume2.5500Open2.5100Pre Close109.58KTurnover4.06%Turnover RatioLossP/E (Static)1.06MShares18.810052wk High0.56P/B2.77MFloat Cap2.167852wk Low--Dividend TTM1.05MShs Float3118.4994Historical High--Div YieldTTM8.87%Amplitude2.1670Historical Low2.5650Avg Price1Lot Size
About Phio Pharmaceuticals Company
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Company Profile
SymbolPHIO
Company NamePhio Pharmaceuticals
Listing DateFeb 11, 2014
Founded2011
CEOMr. Robert J. Bitterman
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address11 Apex Drive,Suite 300A PMB 2006
CityMarlborough
ProvinceMassachusetts
CountryUnited States of America
Zip Code01752
Phone1-508-767-3861
Websitehttp://www.phiopharma.com
Company Executives
- Name
- Position
- Salary
- Robert J. Bitterman
- Chairman of the Board, Chief Executive Officer and President
- 437.89K
- Robert M. Infarinato
- Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Caitlin Kontulis
- Principal Accounting Officer, Vice President, Finance and Administration and Secretary
- --
- Dr. Curtis A. Lockshin, PhD
- Independent Director
- 50.36K
- Robert L. Ferrara
- Lead Independent Director
- 70.36K
- Dr. Jonathan E. Freeman, PhD
- Independent Director
- 42.86K
- Patricia A. Bradford
- Independent Director
- 57.86K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data